Why the study?
Does ambulatory ECG monitoring accurately detect and provide prognostic value for myocardial ischemia in patients with coronary artery disease?
Does ambulatory ECG monitoring accurately detect and provide prognostic value for myocardial ischemia in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
Ambulatory ECG monitoring is not recommended as a screening tool for CAD due to high variability, but it provides valuable prognostic information and helps assess anti-ischemic therapy efficacy in patients with known CAD.
Ambulatory ECG monitoring (AEM) is the only available method to assess the presence and severity of myocardial ischemia during daily life. Several investigators have shown that the recording systems currently used can detect ischemic changes with similar accuracy as treadmill exercise testing. Ischemic changes on AEM are, however, present in only 40%-60% of patients with coronary artery disease (CAD) and positive exercise tests. For this reason, and because of the high day-to-day variability in daily ischemic changes, AEM cannot be used as a screening tool for detecting CAD or for evaluating severity of ischemia in individual patients. In patients with proven CAD, ischemic changes on AEM are associated with an adverse outcome in patients with stable and unstable ischemic syndromes, and in postmyocardial infarction patients. Suppression of daily ischemia seems to be associated with improved outcome. The mechanism of daily ischemia is not identical to exercise-induced ischemia. In addition to increased demand, which is a major contributor to AEM detected-ischemia, increased coronary tone also seems to play a major role. AEM has been shown to be a useful and reliable tool to assess the efficacy of various antiischemic drugs.
No takes yet. Share an insight, caveat, or question.
Dan Tzivoni (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: